HuGE Literature Finder
Records 1-9
|
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
|
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
Journal of the National Cancer Institute 2018 Feb . Weigelt Britta, Bi Rui, Kumar Rahul, Blecua Pedro, Mandelker Diana L, Geyer Felipe C, Pareja Fresia, James Paul A, , Couch Fergus J, Eccles Diana M, Blows Fiona, Pharoah Paul, Li Anqi, Selenica Pier, Lim Raymond S, Jayakumaran Gowtham, Waddell Nic, Shen Ronglai, Norton Larry, Wen Hannah Y, Powell Simon N, Riaz Nadeem, Robson Mark E, Reis-Filho Jorge S, Chenevix-Trench Georg |
|
Racial Disparities in the Molecular Landscape of Cancer.
Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
|
Quantitative mRNA expression analysis of selected genes in patients with early-stage hypothyroidism induced by treatment with iodine-131.
Molecular medicine reports 2015 Sep . Guo Kun, Gao Rui, Yu Yan, Zhang Weixiao, Yang Yuxuan, Yang Aim |
|
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
|
Meta-analysis of associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and adverse effects of cancer radiotherapy.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (24): 10675-81. Su Meng, Yin Zhi-Hua, Wu Wei, Li Xue-Lian, Zhou Bao-S |
|
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Breast cancer research : BCR 2012 14 (2): R47. Knappskog Stian, Chrisanthar Ranjan, Løkkevik Erik, Anker Gun, Østenstad Bjørn, Lundgren Steinar, Risberg Terje, Mjaaland Ingvil, Leirvaag Beryl, Miletic Hrvoje, Lønning Per |
|
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.
Blood 2005 Nov 106 (9): 3175-82. Austen Belinda, Powell Judith E, Alvi Azra, Edwards Ian, Hooper Laura, Starczynski Jane, Taylor A Malcolm R, Fegan Christopher, Moss Paul, Stankovic Tatja |
|
Mutation analysis of the ATR gene in breast and ovarian cancer families.
Breast cancer research : BCR 2005 7 (4): R495-501. Heikkinen Katri, Mansikka Virpi, Karppinen Sanna-Maria, Rapakko Katrin, Winqvist Robe |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jun 16, 2021
- Content source: